Skip to content

Quality-of-life needs to be better measured in osteoporosis

Quality-of-life in osteoporosis is currently not measured adequately and this needs to change to improve outcomes in these patients, the ISR Autumn Meeting heard. UK expert on quality-of-life in patients with arthritis and osteoporosis Dr Marwan Bukhari, Consultant Rheumatologist and Clinical Lead for Rheumatology at the University Hospitals of Morecambe Bay NHS Foundation Trust, pointed…

Read More

Behçet’s disease not as rare as believed, UK expert tells ISR

While classed as a rare autoimmune disease, Behçet’s is far more prevalent than the literature suggests, according to Prof Robert Moots, Professor of Rheumatology, Liverpool Behçet’s disease Centre of Excellence at Aintree University Hospital, UK. “We have more than 250 patients alone coming to the clinic in Liverpool so it is more prevalent in the…

Read More

Fatigue the key issue for patients with lupus

Fatigue is the most debilitating symptom in systemic lupus erythematosus but the current limited understanding of fatigue mechanisms means there is a lack of effective treatment for these patients, an expert in the field told the ISR 2019 Autumn Meeting. “Eighty-to-ninety per cent of patients with lupus report that fatigue is their most profound and…

Read More

New insights into joint damage could help reduce need for joint replacements

New insights into the cellular events triggered by joint-associated particulates could mean the development of treatments that promote repair, thus negating the need for many joint replacements in the future, the 2019 ISR Autumn Meeting in Naas heard. Prof Aisling Dunne, Molecular Immunology Group Lead, Trinity College Dublin, gave a fascinating presentation titled ‘Disease-associated particulates and…

Read More

ISR Bernard Connor Medal winner focuses on rare condition

The winner of the 2019 ISR Bernard Connor Medal was Tereza Florica, a Canadian third-year graduate entry medical student at University College Cork, whose project focuses on myocardial involvement of myositis. Ms Florica gave a well-received presentation at the 2019 ISR Autumn Meeting, where she revealed that during her rheumatology placement in Cork University Hospital, she came across…

Read More

Arthritis Ireland launch book on living with RA

A new book featuring first-hand, personal accounts of living with rheumatoid arthritis (RA), which affects an estimated 45,000 people in Ireland, published by Arthritis Ireland, was showcased at the 2019 ISR Autumn Meeting. My RA Story: Personal accounts of living with rheumatoid arthritis is a collection of more than 40 stories written by people who…

Read More

ISR Autumn Meeting deemed a great success

The 2019 Irish Society for Rheumatology (ISR) Autumn Meeting, which was held in the Killashee Hotel, Naas, from 26-27 September, was deemed a great success, and featured cutting-edge presentations from leading specialist speakers from Ireland and the UK. A holistic approach to aspects of care was at the core of the meeting with pain in…

Read More

Hand osteoarthritis improves with prednisolone

The results of the low-dose prednisolone in patients with hand osteoarthritis (HOPE) study presented at EULAR 2019 show that low-dose prednisolone significantly improves pain and function in patients with painful hand osteoarthritis. Treatments are currently limited to topical and oral non-steroidal anti-inflammatory drugs (NSAIDs) to relieve pain. However, studies have shown that synovial inflammation is…

Read More

Disease control on tocilizumab

The results of a randomised controlled trial presented at EULAR 2019 demonstrate high levels of treatment success in approximately two-thirds of patients despite tapered glucocorticoid (GC) discontinuation, while a small loss of disease control was observed at the total study population level. “On the basis of our results, we believe that all patients achieving low…

Read More

Disease remission associated with 80% reduction in cardiovascular outcomes

Remission in patients with rheumatoid arthritis (RA) is associated with an 80 per cent reduction in risk of cardiovascular outcomes, the results of a study presented at EULAR 2019 show. “The heightened risk of cardiovascular disease in patients with rheumatoid arthritis is in large part a consequence of uncontrolled inflammation. By demonstrating that remission of…

Read More
Scroll To Top